# LIVOSTIN
> **NDA020219** · New Drug Application · Sponsor: NOVARTIS · Approved 1993-11-10
## Drug
- **FDA Application Number:** NDA020219
- **Application type:** New Drug Application
- **Brand name:** LIVOSTIN
- **Generic name:** Levocabastine Hydrochloride
- **Active ingredients:** LEVOCABASTINE HYDROCHLORIDE
- **Dosage form:** SUSPENSION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Discontinued
- **Sponsor:** NOVARTIS
- **First approval:** 1993-11-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020219)
---
*MORVS · CC0 1.0*